Leadscope FDA Model Applier

FDA Symposium on the Use of Leadscope at U.S. FDA/CDER

Tentative Agenda
The Use of Leadscope at U.S. FDA / CDER
9:00 am - 4:30 pm
September 17, 2008
Federal Research Center at White Oak
U.S. Food and Drug Administration

9:00 am	Informatics and QSAR Computational Toxicology at US FDA CDER R. Daniel Benz, FDA/CDER/ICSAS
9:20 am	Leadscope, Inc. Loftus Lucas, CEO Leadscope, Inc.
9:40 am	Predictive Data Mining with Leadscope Chihae Yang, CSO, Leadscope, Inc.
10:30 am	Break
11:00 am	Data Acquisition with the Leadscope ToxML Database Methodology R. Daniel Benz, FDA/CDER/ICSAS
11:30 pm	FDA CFSAN Database Program: Industry Submission to Safety Review Kirk B. Arvidson, FDA/CFSAN/OFAS
12:00 pm	Lunch
1:00 pm	Leadscope FDA Model Applier at FDA CDER Naomi L. Kruhlak and Luis G. Valerio, Jr., FDA/CDER/ICSAS
2:00 pm	FDA's Decision Support Strategy Employing Leadscope and FDA QSAR Models Edwin Matthews, FDA/CDER/ICSAS
3:00 pm	Break
3:30 pm	Leadscope Product Development Kevin Cross, VP of Product Engineering & Production, Leadscope, Inc.
4:30 pm	Adjourn

Email Us if you would like to attend.

The FDA is very pleased to sponsor this gathering of experts to discuss promising new scientific methodologies; however, the meeting should not be construed as an announcement of FDA guidance or regulations, or a FDA endorsement of Leadscope, Inc. products.

Shopping Cart

0 items